SAWAF AZIZ (SVP & CHIEF FINANCIAL OFFICER) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/22/2024ACC: 0001415889-24-022090
Officer· SVP & CHIEF FINANCIAL OFFICER
Since Feb 2026
-8.63K
Net shares
Net seller
$71.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
8.63K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−8.63K
Price / share
$8.22
Trade value
$70.98K
% of position
2.6%
8/20/2024
330K→321.37K
Total
Net shares
−8.63K
Net value
-$70.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/20/2024 | F · Tax Withholding | −8.63K | $8.22 | $70.98K | 2.6% | 330K | 321.37K |
| Total | −8.63K | -$70.98K | ||||||
Derivative Transactions0
No derivative transactions reported